Atai Life Sciences Total Non-Operating Income/Expense 2020-2025 | ATAI

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Atai Life Sciences total non-operating income/expense from 2020 to 2025. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.

Atai Life Sciences Total Non-Operating Income/Expense 2020-2025 | ATAI

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Atai Life Sciences total non-operating income/expense from 2020 to 2025. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.

Related Stocks
Company Name	Market Cap
Quest Diagnostics (DGX)	$18.3B
DaVita (DVA)	$11.2B
Encompass Health (EHC)	$10.4B
Chemed (CHE)	$8.5B
Option Care Health (OPCH)	$5.3B
Elanco Animal Health (ELAN)	$4.2B
RadNet (RDNT)	$3.7B
Amedisys (AMED)	$3B
LifeStance Health (LFST)	$2.6B
Addus HomeCare (ADUS)	$1.8B
Astrana Health (ASTH)	$1.6B
U.S Physical Therapy (USPH)	$1B
Pennant (PNTG)	$907M
Aveanna Healthcare Holdings (AVAH)	$886M
Daxor (DXR)	$36M
Ontrak (OTRK)	$6M
MEDIROM Healthcare Technologies (MRM)	$4M
Psychemedics (PMD)	$0M